Picture of Oncolytics Biotech logo

ONCY — Oncolytics Biotech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Brief: Oncolytics Biotech granted end-of-phase 2 meeting with FDA

July 26 (Reuters) - Oncolytics Biotech Inc  ONC.TO  
    * Oncolytics biotech to present reolysin safety data in 
combination with chemotherapy at esmo 2017 congress 
    * Oncolytics biotech inc - has been granted an end-of-phase 
2 meeting with united states food and drug administration (fda), 
taking place in august 2017. 
    * Oncolytics biotech inc - company expects to announce 
outcome of meeting with fda in q4 of 2017. 
 
Source text for Eikon:  ID:nPn6lMn1Ya  
Further company coverage:  ONC.TO  
 
 ((Bangalore.newsroom@thomsonreuters.com ;))

Recent news on Oncolytics Biotech

See all news